Topic archive

resilient pharmaceuticals

2 stories

10/28/2026

Pharma giants invest billions in psychedelics despite hurdles

Psychedelics like MDMA and psilocybin gain traction amid regulatory challenges.

8/21/2026

Investment in neuroplastogen company highlights growing interest in non-hallucinogenic psychedelics.